Recent reports have focused on the protective role of HO-1 against Con A-induced hepatitis and how HO-1 is being considered as one of the important targets for antioxidant therapeutics (Gambhir et al., 2014; Zhao et al., 2015). This evidence concerns the gene HMOX1 and hepatitis A virus infection.